CLINICAL_TRIALS
trial_result
· 2026-01-22
Clinical Trial Update: Study of [68Ga]FAPI-46 PET in Patients With Pancreatic Ductal Carcinoma [Phase 2]
Summary
Phase 2 clinical trial evaluating the [68Ga]FAPI-46 PET imaging tracer in pancreatic ductal adenocarcinoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: SOFIE | Conditions: PDAC - Pancreatic Ductal Adenocarcinoma, FAP | Phase 2 | Status: COMPLETED